REXAHN PHARMACEUTICALS, INC. 10-Q 6-30-2016

Company

Opus Genetics, Inc.

Filed

August 5, 2016

Period of Report

June 30, 2016

Accession Number

0001140361-16-075030

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →